SCHEMBL25460807

SCHEMBL25460807

CNC(=O)C(C)(C)c1cc(C)cc(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 4/20 0.35
▸ CNR1 P21554 2/20 0.35
▸ PGK1 P00558 1/20 0.34
▸ PGK2 P07205 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HDAC3 O15379 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC2 Q92769 2/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ LTB4R Q15722 1/20 0.33
▸ LTB4R2 Q9NPC1 1/20 0.33
▸ TACR1 P25103 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ XBP1 P17861 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460811 0.91 SLC6A3 (0.40) ALDH1A1HDAC3SLC6A3LTB4RLTB4R2
SCHEMBL25460880 0.84 CA12 (0.40) ALDH1A1SLC6A3LTB4RLTB4R2TACR1
SCHEMBL25460884 0.84 MAPT (0.49) ALDH1A1HDAC3HDAC1HDAC2HDAC6
SCHEMBL25460876 0.83 HDAC3 (0.34) HDAC3SLC6A3LTB4RLTB4R2TACR1
SCHEMBL25167683 0.82 CNR2 (0.51) CNR2CNR1PGK1PGK2ALDH1A1
SCHEMBL25175855 0.81 APP (0.41) CNR2CNR1PGK1PGK2HDAC3
SCHEMBL25460808 0.81 HCAR1 (0.44) HDAC3SLC6A3TACR1MEN1KMT2A
SCHEMBL25460883 0.80 AKR1C3 (0.39) ALDH1A1MAPTNPC1RAB9A
SCHEMBL25460797 0.80 PARP1 (0.39) ALDH1A1HDAC3SLC6A3HSD11B1
SCHEMBL25460782 0.77 KCNN4 (0.50) CNR2CNR1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR CNR2 217/4885CNR1 125/4885PGK1 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback